---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-028146"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T16:47:27.888331+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences prices $200M underwritten offering; extends cash runway into first half 2027

## Summary
- Priced $200M underwritten offering expected to close Feb 19, 2025; net proceeds to fund R&D for SGT-003 and other candidates.
- Company estimates cash runway into first half of 2027, but notes offering alone may not fully fund development of all candidates.
- Remaining proceeds for general corporate purposes; existing cash and securities combined for operating plan.

## SEC filing metadata
- accession: 0001193125-25-028146
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312525028146/0001193125-25-028146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312525028146/d916580d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-028146
- JSON: https://secwatch.observer/filing/0001193125-25-028146.json
- Plain text: https://secwatch.observer/filing/0001193125-25-028146.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.